Table 1.

Patient and tumor characteristics.

Patient and HFRT Tumor Target Characteristics (n = 49, except as annotated)
Median age at HFRT (IQR)			62 (48–73)
Sex			n	%
	Male		22	45 %
	Female		27	55 %
White race			43	88 %
Melanoma subtype			n	%
	Mucosal		11	22 %
	Cutaneous		38	78 %
Mutation status
	BRAF (n = 44 evaluated)		18	41 %
	NRAS (n = 42 evaluated)		6	14 %
	cKIT (n = 42 evaluated)		4	10 %
ECOG status at time of HFRT (n = 51)
	PS 0		15	29 %
	PS 1		22	43 %
	PS 2		10	20 %
	PS 3		4	8 %
HFRT tumor target anatomic site (n = 53)
	Head and neck		6	11 %
	Trunk		30	57 %
	Extremities		7	13 %
	Mucosal		10	19 %
Median tumor target size (cm, IQR)			6 (3.8–10)

ECOG: Eastern Cooperative Oncology Group, HFRT: hypofractionated radiation therapy, IQR: interquartile range, n = number of patients.